Stocks to Watch: Verint, Liminatus, Five Below

Dow Jones

Jun 05

By Katherine Hamilton

Verint Systems beat Wall Street expectations with its first-quarter financial sales and adjusted earnings. Shares climbed 19% to $21.89 in postmarket trading Wednesday.

Liminatus Pharma said it regained compliance with Nasdaq listing requirements. It filed its delayed 10-Q on Monday after receiving a noncompliance notice on May 29. Shares jumped 72% to $21.88 after the market closed.

Five Below logged higher-than-expected sales in the first quarter, and said it expects its outperformance to continue into the second quarter. It raised its sales outlook for the full year, though new tariff costs are moderating other metrics. Shares advanced 4% to $125.75 after market close.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

June 04, 2025 19:32 ET (23:32 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2541097543"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541097543\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2541097543?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 07:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541097543","market":"hk","top_or_hot":-1,"title":"Stocks to Watch: Verint, Liminatus, Five Below","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  Verint Systems beat Wall Street expectations with its first-quarter financial sales and adjusted earnings. Shares climbed 19% to $21.89 in postmarket trading Wednesday. \n</p>\n<pre>\n \n</pre>\n<p>\n  Liminatus Pharma said it regained compliance with Nasdaq listing requirements. It filed its delayed 10-Q on Monday after receiving a noncompliance notice on May 29. Shares jumped 72% to $21.88 after the market closed. \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/FIVE\">Five Below</a> logged higher-than-expected sales in the first quarter, and said it expects its outperformance to continue into the second quarter. It raised its sales outlook for the full year, though new tariff costs are moderating other metrics. Shares advanced 4% to $125.75 after market close. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 04, 2025 19:32 ET (23:32 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks to Watch: Verint, Liminatus, Five Below</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks to Watch: Verint, Liminatus, Five Below\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-06-05 07:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  Verint Systems beat Wall Street expectations with its first-quarter financial sales and adjusted earnings. Shares climbed 19% to $21.89 in postmarket trading Wednesday. \n</p>\n<pre>\n \n</pre>\n<p>\n  Liminatus Pharma said it regained compliance with Nasdaq listing requirements. It filed its delayed 10-Q on Monday after receiving a noncompliance notice on May 29. Shares jumped 72% to $21.88 after the market closed. \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/FIVE\">Five Below</a> logged higher-than-expected sales in the first quarter, and said it expects its outperformance to continue into the second quarter. It raised its sales outlook for the full year, though new tariff costs are moderating other metrics. Shares advanced 4% to $125.75 after market close. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 04, 2025 19:32 ET (23:32 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4023","symbol_name":"应用软件","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2541097543","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541097543","pubTimestamp":1749079920,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Verint Systems beat Wall Street expectations with its first-quarter financial sales and adjusted earnings. Shares climbed 19% to $21.89 in postmarket trading Wednesday.Liminatus Pharma said it regained compliance with Nasdaq listing requirements. It filed its delayed 10-Q on Monday after receiving a noncompliance notice on May 29. Shares jumped 72% to $21.88 after the market closed.Five Below logged higher-than-expected sales in the first quarter, and said it expects its outperformance to continue into the second quarter. It raised its sales outlook for the full year, though new tariff costs are moderating other metrics. Shares advanced 4% to $125.75 after market close.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4023":"应用软件","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","BK4139":"生物科技","VRNT":"Verint Systems Inc","FIVE":"Five Below","LU0566484027.USD":"安本美国小盘成长股","LIMN":"Liminatus Pharma LLC","BK4200":"专卖店"},"translate_title":"值得关注的股票：Verint、Liminatus、Five Below","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FIVE":1,"LIMN":0.9,"VRNT":1},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  Verint Systems beat Wall Street expectations with its first-quarter financial sales and adjusted earnings. Shares climbed 19% to $21.89 in postmarket trading Wednesday. \n\n\n \n\n\n  Liminatus Pharma said it regained compliance with Nasdaq listing requirements. It filed its delayed 10-Q on Monday after receiving a noncompliance notice on May 29. Shares jumped 72% to $21.88 after the market closed. \n\n\n \n\n\nFive Below logged higher-than-expected sales in the first quarter, and said it expects its outperformance to continue into the second quarter. It raised its sales outlook for the full year, though new tariff costs are moderating other metrics. Shares advanced 4% to $125.75 after market close. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 04, 2025 19:32 ET (23:32 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}